169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Poultry viral materials and methods related thereto
#4802RSPONDIN-3 INHIBITION IN BONE DISORDERS
#4803CD93 or use of soluble fragment thereof
#4804PHOSPHORYCHOLINE CONJUGATES AND CORRESPONDING ANTIBODIES
#4805Methods for diagnosing cancer and decreasing metastasis by cancer cells
#4806METHOD AND MARKER FOR DIAGNOSIS OF TUBULAR KIDNEY DAMAGE AND ILLNESSES
#4807Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular risk
#4808METHOD FOR ASSESSING INFLAMMATORY CONDITION
#4809PREDICTION OF NON-FATAL AND FATAL ATHEROTHROMBOTIC EVENTS
#4810Method for detecting presumed IgA nephropathy and method for screening IgA nephropathy patients
#4811USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER
#4812Method of treating renal dysfunction based on perlecan as a biomarker
#4813Methods for testing for caloric restriction (CR) mimetics
#4814GALECTIN-3 AND STATIN THERAPY
#4815METHODS AND REAGENTS FOR DIAGNOSING ATHEROMA
#4816HIGHLY SENSITIVE DETECTION METHOD FOR HIGHLY VIRULENT ORAL CAVITY BACTERIA
#4817METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#4818Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
#4819METHODS FOR DIAGNOSING KIDNEY DAMAGE ASSOCIATED WITH HEART FAILURE
#4820PROTEIN KINASE C GAMMA AS A BIOMARKER FOR NEUROPSYCHOLOGICAL AND COGNITIVE FUNCTIONS IN THE CENTRAL NERVOUS SYSTEM
#4821Method of predicting acute appendicitis
#4822DOSING AND MONITORING PATIENTS ON NITROGEN-SCAVENGING DRUGS
#4823Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation
#4824DETECTION OF CARCINOMA IN SITU IN SEMEN SPECIMENS
#4825Methods of detecting and treating pulmonary disease and markers thereof
#4826METHOD FOR DIAGNOSIS OF CYSTIC FIBROSIS USING KL-6 LEVELS
#4827Markers for detection of complications resulting from in utero encounters
#4828DIAGNOSTIC METHODS USING BNP
#4829Method of treating lupus nephritis
#4830Chimeric RGMa polypeptides
#4831BIOMARKERS FOR DIAGNOSIS OF TRANSIENT ISCHEMIC ATTACKS
#4832Devices and Methods for Enrichment and Alteration of Circulating Tumor Cells and Other Particles
#4833MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT
#4834Diagnostic marker for type 1 diabetes mellitus
#4835BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS
#4836Methods for detecting a infection
#4837Non-Invasive Method for Assessing Liver Fibrosis Progression
#4838Detection of specific nitrated markers
#4839GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
#4840Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases
#4841METHODS FOR DIAGNOSIS AND PROGNOSIS OF PULMONARY HYPERTENSION
#4842DETECTING AND MONITORING LEFT VENTRICULAR HYPERTROPHY AND CONGESTIVE HEART FAILURE BY PROFILING BIOMARKERS
#4843Thyroglobulin quantitation by mass spectrometry
#4844BIOMARKER FOR THE MONITORING AND PROGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS
#4845DIFFERENTIATING CARDIAC- AND DIABETES MELLITUS-BASED CAUSES OF KIDNEY DAMAGE
#4846Peptide biomarkers predictive of renal function decline and kidney disease
#4847Method for identifying an antagonist of guanine nucleotide releasing factor 1
#4848METHOD OF DIAGNOSING ADOLESCENT IDIOPATHIC SCOLIOSIS
#4849Biomarker for Barrett's Oesophagus
#4850ANALYSIS METHOD FOR THE IN VITRO DIAGNOSIS OF BENIGN PROSTATIC HYPERPLASIA (BPH) IN DOGS BY ASSAYING CANINE PROSTATE SPECIFIC ESTERASE, AND BPH TREATMENT FOLLOW UP
#4851ENPP1 (PC-1) GENE HAPLOTYPE ASSOCIATED WITH THE RISK OF OBESITY AND TYPE 2 DIABETES AND THEIR APPLICATIONS
#4852Monocyte-derived nucleic acids and related compositions and methods
#4853Biomarkers for myocardial ischemia
#4854METHOD FOR THE DIAGNOSIS OF AGE-ASSOCIATED VASCULAR DISORDERS
#4855Diagnostic Marker for Migraine and Use Thereof
#4856Methods, products and treatments for diabetes
#4857BIOMARKER FOR THE PREDICTION OF FIRST ADVERSE EVENTS
#4858Fructosyl peptide oxidase
#4859IN VITRO-METHOD FOR THE DIAGNOSIS, PROGNOSIS, MONITORING AND THERAPY FOLLOW-UP OF DISORDERS ASSOCIATED WITH THE METABOLIC SYNDROME, A CARDIOVASCULAR DISEASE AND/OR INSULIN RESISTANCE
#4860Dissolved protein arthritis markers
#4861METHODS AND KITS FOR DETERMINING PREDISPOSITION TO DEVELOP KIDNEY DISEASES
#4862Novel composition and methods for the treatment of psoriasis
#4863METHODS FOR APCDD1 MEDIATED REGULATION OF HAIR GROWTH AND PIGMENTATION AND MUTANTS THEREOF
#4864Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II)
#4865METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS
#4866Compositions and Methods to Treat Bone Related Disorders
#4867Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
#4868Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
#4869CVD ASSAY
#4870METHOD OF SCREENING PLACENTAL PROTEINS RESPONSIBLE FOR PATHOPHYSIOLOGY OF PREECLAMPSIA, AND MARKER FOR EARLY DIAGNOSIS AND PREDICTION OF PREECLAMPSIA
#4871Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases
#4872Methods and kits for predicting a response to an erythropoietic agent
#4873BIOMARKERS FOR PERIPHERAL ARTERY DISEASE
#4874NON-INVASIVE IN VITRO METHOD FOR QUANTIFYING LIVER LESIONS
#4875SOLUBLE ICAM-1 AS BIOMARKER FOR PREDICTION OF THERAPEUTIC RESPONSE
#4876Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases
#4877Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals
#4878Monoclonal antibody and use thereof
#4879METHOD FOR THE DIAGNOSIS OF SYSTEMIC SCLERODERMA OR OF PULMONARY ARTERIAL HYPERTENSION
#4880MULTIPLEXED BIOMARKERS OF INSULIN RESISTANCE
#4881PHARMACEUTICAL COMPOSITION AND METHOD FOR IDENTIFYING A CANCEROUS AND/OR AN INFLAMMATORY DISEASE IN A PATIENT
#4882METHODS AND COMPOSITIONS FOR DETECTING CANINE DILATED CARDIOMYOPATHY (DCM)
#4883Methods for identifying analgesic agents
#4884Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1
#4885Corin As A Marker For Heart Failure
#4886Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#4887Antibody to cytolethal distending toxin of
#4888Compositions and methods for treatment of angiogenesis-associated ocular disorders
#4889Anti-αβantibodies and uses thereof
#4890Compositions for proliferation of cells and related methods
#4891Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
#4892Risk assessment for cutaneous adverse drug reactions from antiretroviral agent
#4893Methods for differentiating and monitoring parathyroid and bone status related diseases
#4894Autosomal-Dominant Polycystic Kidney Disease (ADPKD)
#4895Methods for detecting, diagnosing and treating human renal cell carcinoma
#4896BIOMARKERS
#4897Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy
#4898Reagents and methods for detecting a polymorphic protein
#4899Agents for the treatment of celiac disease
#4900Modulation of splenocytes in cell therapy
#4901Treatment of chronic pelvic pain syndrome
#4902ANNEXIN A2 AS IMMUNOLOGICAL TARGET
#4903Antisense modulation of interleukins 17 and 23 signaling
#4904Methods of identifying adipocyte specific genes, the genes identified, and their uses
#4905URINARY BIOMARKERS FOR SENSITIVE AND SPECIFIC DETECTION OF ACUTE KIDNEY INJURY IN HUMANS
#4906POLYPEPTIDE MARKER FOR DIAGNOSIS OF ARTERIOSCLEROSIS, METHOD FOR DETECTION OF ARTERIOSCLEROSIS BY USING THE MAKER OR THE LIKE, AND KIT FOR DIAGNOSIS OF ARTERIOSCLEROSIS
#4907METHOD AND COMPOSITION FOR THE DIAGNOSIS AND MONITORING OF INFLAMMATORY DISEASES
#4908Compositions and methods for diagnosing and treating an inflammation
#4909Methods and Kits for the Rapid Determination of Patients at High Risk of Death During Severe Sepsis and Septic Shock
#4910Compositions and methods for diagnosing and treating an inflammation
#4911Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
#4912METHODS AFFECTING MARKERS IN PATIENTS HAVING VASCULAR DISEASE
#4913Identifying High Risk Clinically Isolated Syndrome Patients
#4914BIOMARKER
#4915METHOD AND MARKER FOR DIAGNOSING DIABETES MELLITUS
#4916Assay for Detecting Cathepsin K Activty in Bone, Cartilage and/or Soft Tissue
#4917Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
#4918Methods for treatment of cardiovascular disease
#4919Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
#4920BIOMARKER FOR DIAGNOSIS, PREDICTION AND/OR PROGNOSIS OF ACUTE HEART FAILURE AND USES THEREOF
#4921MARKER SEQUENCES FOR INFLAMMATORY PROSTATE DISEASES, PROSTATE CARCINOMA AND THEIR USE
#4922DIAGNOSTIC BIOMARKERS OF DIABETES
#4923Erk1/2 posphorylation site specific antibody
#4924COLON DISEASE TARGETS AND USES THEREOF
#4925BIO-MARKERS FOR DIAGNOSING DIABETIC RETINOPATHY
#4926MEASURING LEVELS OF FRATAXIN
#4927Methods and kits for detection of toxemia
#4928UBIQUITIN PROTEASOME SYSTEM PROFILING FOR DIAGNOSIS OF CHRONIC LIVER DISEASE
#4929Methods for diagnosis, prognosis and methods of treatment
#4930Compositions and methods for predicting cardiovascular events
#4931TUBERCULOSIS ANTIGEN DETECTION ASSAYS AND VACCINES
#4932PCTP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#4933CCR3 inhibition for ocular angiogenesis and macular degeneration
#4934PROGNOSIS AND RISK ASSESSMENT IN STROKE PATIENTS BY DETERMINING THE LEVEL OF MARKER PEPTIDES
#4935Pirfenidone treatment for patients with atypical liver function
#4936METHOD FOR THE PROGNOSIS AND DIAGNOSIS OF TYPE II DIABETES IN CRITICAL PERSONS
#4937Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
#4938Predicting mortality and detecting severe disease
#4939MAST CELL CARBOXYPEPTIDASE AS A MARKER FOR ANAPHYLAXIS AND MASTOCYTOSIS
#4940MODULATORS OF ISOVALERYL-COENZYME A DEHYDROGENASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#4941Method for determination of oxidative stress
#4942Methods of Using SDF-1 (CXCL12) as a Diagnostic and Mesenchymal Stem Cell (Multipotent Stromal Cell)-Specific Therapeutic Biomarker for the Treatment of Kidney Injury and Other Major Organs
#4943Biomarkers of Mineralocorticoid Receptor Activation
#4944Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof
#4945METHOD OF CLASSIFYING HUMAN SUBJECTS HAVING ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS) AND METHOD FOR SCREENING FOR A COMPOUND USEFUL IN THE TREATMENT OF AIS AND RELATED SYNDROMES CAUSING SPINAL DEFORMITIES
#4946Method for detecting lysosomal storage diseases
#4947LIVER DISEASE MARKER, METHOD AND APPARATUS FOR MEASURING THE SAME, AND METHOD FOR ASSAYING PHARMACEUTICAL PREPARATION
#4948Use of cytokine receptors as biomarkers and therapeutic targets in human cancer
#4949NOVEL POLYPEPTIDES RELATED TO B-TYPE NATRIURETIC PEPTIDES AND METHODS OF THEIR IDENTIFICATION AND USE
#4950Cardiac stem cell and myocyte secreted paracrine factors
#4951MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES
#4952APPLICATION OF 99MTC PEPTIDE-BASED COMPOUND AS A BONE MARROW IMAGING AGENT
#4953Novel gene disruptions, compositions and methods relating thereto
#4954Health test for a broad spectrum of health problems
#4955Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples
#4956IL1RL-1 as a cardiovascular disease marker and therapeutic target
#4957Biomarker and method for detecting a chronic inflammatory-associated disease
#4958BIOMARKERS AND ASSAYS FOR DIABETES
#4959MARKER FOR CANCER PROGNOSIS AND METHODS RELATED THERETO
#4960Screening Method for Identifying Patients at Risk of Adverse Hepatologic Events
#4961Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator
#4962DIAGNOSING AND MONITORING DEPRESSION DISORDERS BASED ON MULTIPLE SERUM BIOMARKER PANELS
#4963COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#4964EGFR DEPENDENT MODULATION OF CHEMOKINE EXPRESSION AND INFLUENCE ON THERAPY AND DIAGNOSIS OF TUMORS AND SIDE EFFECTS THEREOF
#4965Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
#4966Immunoassays for citrullinated proteins
#4967Method for detecting human BPLP protein or a maturation product thereof
#4968Detection and monitoring of liver damage
#4969METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#4970Chitin-induced immune response based method for diagnosing allergic asthma in patients
#4971Method for diagnosing and creating immunogenic tolerance in contact allergy and other epithelial immunotoxicological ailments
#4972Method for treating or preventing a pancreatic dysfunction
#4973METHOD OF DIAGNOSING A RESPIRATORY DISEASE
#4974LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#4975MARKER FOR DIAGNOSIS OF EXPOSURE TO ELECTROMAGNETIC RADIATION AND DIAGNOSTIC KIT COMPRISING THE SAME
#4976Method for measuring cystatin C in human body fluid
#4977Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#4978Chemical and biochemical adducts as biomarkers for organophosphate exposure
#4979Method for diagnosing immunoglobulin A nephropathy and TGBM nephropathy
#4980NOVEL METHOD FOR PREDICTION OF CARDIOVASCULAR DISEASE RISK IN TYPE 2 DIABETES
#4981METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
#4982Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event
#4983METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#4984USE OF CARDIAC HORMONES TO ASSESS RISK OF CARDIOVASCULAR COMPLICATION FROM VOLUME OVERLOAD
#4985COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RLATED TO BECLIN-1
#4986METHOD FOR DIAGNOSING POLYCYSTIC KIDNEY DISEASE
#4987Methods and Compositions for Determining Predisposition to Inflammation-Mediated Cardiovascular Disease
#4988Biochemical Markers for Disease States and Genes for Identification of Biochemical Defects
#4989METHODS FOR PREDICTING DEVELOPMENT OF AUTO-IMMUNE DISEASES AND TREATMENT OF SAME
#4990METHODS FOR REDUCING THE LIKELIHOOD OF SPONTANEOUS ABORTION DURING ASSISTED REPRODUCTION IN A SUBJECT
#4991COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MENTAL DISORDERS
#4992Oxidized APOA1 determination by mass spectrometry
#4993DETECTION OF SPECIFIC NITRATED MARKERS
#4994Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism
#4995Gene defects and mutant ALK kinase in human solid tumors
#4996Granin proteins as markers of heart disease
#4997CD3 epsilon immunogens and antibodies
#4998Prognostic Marker for Endometrial Carcinoma
#4999Multiple Biomarker Panels to Stratify Disease Severity and Monitor Treatment of Depression
#5000Method to predict response to pharmacological chaperone treatment of diseases
#5001NOVEL DIAGNOSTIC METHOD
#5002Compositions and methods relating to monitoring alcohol consumption and alcohol abuse
#5003Biomarkers for predicting the sensitivity and response of protein kinase CK2-mediated diseases to CK2 Inhibitors
#5004METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36
#5005GAMMACARBOXYGLUTAMATE-RICH PROTEIN, METHODS AND ASSAYS FOR ITS DETECTION, PURIFICATION AND QUANTIFICATION AND USES THEREOF
#5006INFLAMMATORY BOWEL DISEASE BIOMARKERS AND RELATED METHODS OF TREATMENT
#5007Marker for inflammatory conditions
#5008METHOD AND SOFTWARE FOR CARDIOVASCULAR ASSESSMENT AND RISK DETECTION
#5009PREDICTING CARDIOVASCULAR EVENTS AND RENAL FAILURE IN TYPE 1 DIABETICS
#5010METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#5011Methods for detecting the presence of expanded CGG repeats in the FMR1 gene 5′ untranslated region
#5012Differential gene expression in physiological and pathological angiogenesis
#5013WNT1 AS A RENAL DAMAGE BIOMARKER
#5014Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
#5015Healthy kidney biomarkers
#5016Tuberculosis diagnostic test
#5017Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#5018Endometriosis markers
#5019Chitosan having tropomyosin content assessed by method of determining tropomyosin in chitosan
#5020METHODS AND COMPOSITIONS FOR DETECTING RECESSIVE FAMILIAL FSGS AND USES THEREOF
#5021Method for measuring human megalin
#5022Method and apparatus for analyzing vitamin E in lipoproteins
#5023METHODS AND COMPOSITIONS FOR MITIGATING EOSINOPHILIC ESOPHAGITIS BY MODULATING LEVELS AND ACTIVITY OF EOTAXIN-3
#5024Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha
#5025Methods for diagnosing acute kidney injury or renal failure
#5026COMPOSITION, KIT, AND METHOD FOR ASSAYING AGEING AND DISEASE ACCOMPANIED WITH VASCULAR DISORDER
#5027Integrated Method for Enriching and Detecting Rare Cells from Biological Body Fluid Sample
#5028Antibody drug conjugate treatment of colorectal cancer
#5029DIAGNOSIS AND TREATMENT OF BACK PAIN
#5030METHODS OF DIAGNOSING CHRONIC CARDIAC ALLOGRAFT REJECTION
#5031TREATMENT OF POMPE DISEASE WITH SPECIFIC PHARMACOLOGICAL CHAPERONES AND MONITORING TREATMENT USING SURROGATE MARkERS
#5032Protein Biomarkers and Methods for Diagnosing Kawasaki Disease
#5033METHODS OF USING JAK3 GENETIC VARIANTS TO DIAGNOSE AND PREDICT CROHN'S DISEASE
#5034MODULATION OF BONE DEVELOPMENT
#5035Compositions and methods for diagnosing and treating an inflammation
#5036METHODS AND COMPOSITIONS FOR ALTERING BEHAVIOR ASSOCIATED WITH AUTISM SPECTRUM DISORDER
#5037Diagnostic methods for congestive heart failure
#5038Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertension
#5039Serpine2 as a biomarker for IgA nephropathy
#5040Method and Kit for Use in the Differentiation of IBD and IBS and Further Distinction Between Disease Types of IBD
#5041Diagnostics and Therapeutics for Macular Degeneration-Related Disorders
#5042COMPOSITIONS AND METHODS FOR THE TREATMENT OF NATURAL KILLER CELL RELATED DISEASES
#5043Biomarkers for painful intervertebral discs and methods of use thereof
#5044Methods and Compounds for Promoting Vessel Regression
#5045Antibody against oxidized LDL/βGPI complex and use of the same
#5046Method for the diagnosis of non-alcoholic steatohepatitis based on a metabolomic profile
#5047Methods and Devices for Detecting Kidney Transplant Rejection
#5048Use of periostin as a novel biomarker
#5049Rapid nasal assay kit
#5050Methods for detecting inflammatory bowel disease
#5051PREDICTING AND REDUCING ALLOIMMUNOGENICITY OF PROTEIN THERAPEUTICS
#5052Oxidative stress responsive apoptosis inducing protein eIF5A
#5053Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
#5054VEGF polymorphisms and anti-angiogenesis therapy
#5055Categorically ranking animals for feed efficiency
#5056Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#5057Marker for graft failure and mortality
#5058Method for diagnosing acute cardiac ischemia
#5059P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH B-1 INTEGRIN ACTIVATION
#5060METHODS AND REAGENTS FOR DETECTING SUSCEPTIBILITY TO GRAFT VERSUS HOST DISEASE OR TRANSPLANT RELATED MORTALITY
#5061METHODS OF DIAGNOSING ACUTE CARDIAC ALLOGRAFT REJECTION
#5062Methods of diagnosing endometriosis
#5063NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR
#5064Methods for detection of biological substances
#5065CATESTATIN (CST) AND ITS VARIANTS FOR TREATMENT OF CARDIOVASCULAR AND METABOLIC DISORDERS
#5066USE OF BIGLYCAN IN THE ASSESSMENT OF HEART FAILURE
#5067METHODS AND BIOMARKERS FOR DIAGNOSING AND MONITORING PSYCHOTIC DISORDERS
#5068THERAPEUTIC AGENT AND DETECTION REAGENT FOR ARTERIOSCLEROTIC DISEASE WHICH TARGETS FOR SALUSIN
#5069Biomarker for Mitochondrial Toxicity Associated with Phospholipidosis
#5070Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
#5071NATRIURETIC PEPTIDES AND ADIPONECTIN IN SUBJECTS WITH A METABOLIC SYNDROME
#5072Methods for diagnosing irritable bowel syndrome
#5073Methods and systems for predicting response of cells to a therapeutic agent
#5074Anti-VEGF antibodies
#5075Methods for Identifying Subjects With an Increased Likelihood of Responding to DPP-IV Inhibitors
#5076Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
#5077Method for evaluating myocardial ischemic state using blood sample
#5078Method of detecting articular cartilage degeneration or damage
#5079Detection and monitoring of liver damage
#5080Beta-2 microglobulin as a biomarker for peripheral artery disease
#5081Method for testing and treating delayed food allergies
#5082SCREENING FOR MODULATORS OF CES1 AND/OR CES3 FOR THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#5083MODULATORS OF ACETYL-COENZYME A ACYLTRANSFERASE 1 OR 2 IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#5084MODULATORS OF CARNITINE OCTANOYLTRANSFERASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#5085BIOMARKER ASSAY FOR DIAGNOSIS AND CLASSIFICATION OF CARDIOVASCULAR DISEASE
#5086Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure
#5087ENDOTHELIAL BASEMENT MEMBRANE TARGETING PEPTIDE LIGANDS
#5088METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#5089Albumin-bound protein/peptide complex as a biomarker for disease
#5090DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#5091Procollagen C-proteinase enhancer (PCPE) biomarker for bone formation
#5092Method for determining treatment of disseminated intravascular coagulation
#5093METHOD FOR DIAGNOSING AND TREATING EMPHYSEMA
#5094DEFICIENCY IN THE HISTONE DEMETHYLASE JHDM2A RESULTS IN IMPAIRED ENERGY EXPENDITURE AND OBESITY
#5095Biomarkers and methods for measuring and monitoring inflammatory disease activity
#5096Risk factors and prediction of myocardial infarction
#5097TETRAHYDRO-ISOALPHA ACID COMPOSITIONS AND METHODS FOR WEIGHT MANAGEMENT
#5098Survivin, a protein that inhibits cellular apoptosis, and its modulation
#5099Methods for identifying and monitoring drug side effects
#5100TYPE II DIABETES MOLECULAR BIOPROFILE AND METHOD AND SYSTEM OF USING THE SAME